Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, cash reserves at AN2 Therapeutics Inc fell by 11.57m. Cash Flow from Financing totalled 84.99m or -- of revenues. In addition the company used 53.29m for operations while cash used for investing totalled 43.28m.
Cash flow per share | -- |
---|---|
Price/Cash flow per share | -- |
Book value per share | 2.94 |
---|---|
Tangible book value per share | 2.94 |
More ▼
Balance sheet in USDView more
Current ratio | 9.75 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼